Table 1.

Application of clinically approved photosensitisers for treatment of cancer.

Photosensitisers	Application	References
NPe6 (Talaporfin sodium)	Non-small cell lung carcinoma	[37]
Motexafin lutetium	Prostate cancer	[38]
Temoporfin	Head, neck, prostate and pancreatic cancers	[39,40,41]
Porfimer sodium	Obstructive oesophageal, lung, bladder and cervical cancers	[28,42,43]
2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a	Head, lung and neck cancers, basal cell carcinoma	[44,45,46]
Hexaminolevulinate	Bladder cancer	[47]
Methyl aminolevulinate	Basal cell carcinoma	[40,48,49]
Aluminium phthalocyanine tetrasulfonate	Lung, breast, skin and stomach cancers	[50]
Padeliporfin	Early-stage of prostate cancer	[51]
Verteporfin	Basal cell carcinoma	[52,53]